| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 10.876 | 23.710 | 9.478 | 5.363 | 29.053 | 49.345 |
| Total Income - EUR | - | - | - | - | 10.876 | 23.710 | 9.478 | 5.363 | 29.053 | 53.688 |
| Total Expenses - EUR | - | - | - | - | 1.051 | 7.839 | 2.400 | 446 | 10.069 | 35.280 |
| Gross Profit/Loss - EUR | - | - | - | - | 9.824 | 15.871 | 7.078 | 4.918 | 18.984 | 18.408 |
| Net Profit/Loss - EUR | - | - | - | - | 9.498 | 15.159 | 6.967 | 4.776 | 18.737 | 17.108 |
| Employees | - | - | - | - | 0 | 0 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Feraclinic Cardio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 728 | 262 | 0 | 9.633 | 34.734 |
| Current Assets | - | - | - | - | 17.756 | 33.609 | 9.007 | 13.512 | 21.720 | 20.411 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 409 | 218 | 45 | 45 | 5.115 | 6.364 |
| Cash | - | - | - | - | 17.347 | 33.391 | 8.962 | 13.467 | 16.606 | 14.047 |
| Shareholders Funds | - | - | - | - | 9.539 | 24.518 | 7.016 | 11.814 | 30.060 | 35.665 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 8.217 | 9.820 | 2.253 | 1.698 | 1.293 | 19.480 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Feraclinic Cardio S.r.l.